Carboplatin and Enterococcal bacteraemia - a phase IV clinical study of FDA data

Summary:

Enterococcal bacteraemia is reported as a side effect among people who take Carboplatin (carboplatin), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Decadron, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Enterococcal bacteraemia when taking Carboplatin. It is created by eHealthMe based on reports of 127,949 people who have side effects when taking Carboplatin from the FDA, and is updated regularly.

What is Carboplatin?

Carboplatin has active ingredients of carboplatin. It is often used in cancer. eHealthMe is studying from 128,210 Carboplatin users. Check the latest studies of Carboplatin.

What is Enterococcal bacteraemia?

Enterococcal bacteraemia (presence of bacteria lactic acid in the blood) is found to be associated with 213 drugs and 330 conditions by eHealthMe. Check the latest studies of Enterococcal bacteraemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

127,949 people reported to have side effects when taking Carboplatin.
Among them, 15 people (0.01%) have Enterococcal bacteraemia.

Could Carboplatin cause Enterococcal bacteraemia?

Among these 15 people:

How long have people been on Carboplatin when they have Enterococcal bacteraemia? *

What is the gender of people who have Enterococcal bacteraemia when taking Carboplatin? *

female: 50 %
male: 50 %

What is the age of people who have Enterococcal bacteraemia when taking Carboplatin? *

What are other drugs people take besides Carboplatin? *

What are other side effects people have besides Enterococcal bacteraemia? *

Pneumonia: 5 people, 33.33%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 4 people, 26.67%
Fatigue (feeling of tiredness): 4 people, 26.67%
Malignant Neoplasm Progression (cancer tumour came back): 4 people, 26.67%
Febrile Neutropenia (fever with reduced white blood cells): 4 people, 26.67%
Septic Shock (shock due to blood infection): 4 people, 26.67%
Hypophagia (reduced food intake): 3 people, 20.00%
Hypovolaemia (a decreased volume of circulating blood in the body): 3 people, 20.00%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 3 people, 20.00%
Staphylococcal Infection (an infection with staphylococcus bacteria): 3 people, 20.00%

What are the existing conditions these people have? *

Tonsil Cancer: 3 people, 20.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 20.00%
Malignant Melanoma Stage Iv (the cancer has spread to other places in the body, such as the lung, liver, brain, bone, soft tissue, or gastrointestinal (gi) tract. cancer may have spread to places in the skin far away from where it first started): 1 person, 6.67%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 6.67%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 1 person, 6.67%
Epstein-Barr Viraemia: 1 person, 6.67%
Hepatotoxicity (chemical-driven liver damage): 1 person, 6.67%
Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 1 person, 6.67%
Malignant Melanoma (skin cancer rises from melancytes): 1 person, 6.67%
Nephropathy Toxic (damage to kidney due to toxins): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Carboplatin and have Enterococcal bacteraemia?

- Check whether Enterococcal bacteraemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carboplatin:

Carboplatin (128,210 reports)

Browse all side effects of Carboplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Enterococcal bacteraemia:

Enterococcal bacteraemia (213 drugs)

Browse all the conditions that are associated with Enterococcal bacteraemia:

Enterococcal bacteraemia (330 conditions)

Related publications that referenced our studies

Zakaria S, Lu KY, Nussenblatt V, Browner I, "Atrial flutter associated with carboplatin administration", Annals of Pharmacotherapy, 2011 Nov .
Zakaria S, Lu KY, Nussenblatt V, Browner I, "Atrial flutter associated with carboplatin administration", Annals of Pharmacotherapy, 2011 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on carboplatin (the active ingredients of Carboplatin) and Carboplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.